Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel rare earth catalyzed synthesis offers high yield and mild conditions for aminoisoindole derivatives, ensuring cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel zirconium catalyst method for chiral alpha-hydroxy-beta-keto esters. High yield, excellent ee, cost-effective industrial scale-up for pharmaceutical intermediates.
Novel cobalt-catalyzed asymmetric double hydroboration for high-purity chiral 1,5-diboron intermediates. Enables cost-effective synthesis of Preclamol and advanced materials.
Patent CN108164435B details a solvent-free, Ru/C-catalyzed route for arylacrylonitriles, offering significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Patent CN103833507B reveals high-efficiency blue OLED materials with simplified synthesis, offering significant supply chain stability and cost reduction potential for electronic chemical manufacturing.
Patent CN105384710B reveals a high-yield furan synthesis method. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediate manufacturing.
Patent CN117430509A reveals novel dialkylation method for high-purity valproic acid intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN102153501A details a metal-free organocatalytic synthesis of chiral pyrrolidines and piperidines with high enantioselectivity, offering cost-effective routes for pharmaceutical intermediates.
Novel patent CN103864588B offers eco-friendly synthesis. Reduces toxicity, improves yield for reliable pharmaceutical intermediate supply chains.
Novel organocatalysts for asymmetric aldol reactions offering high ee/dr and recyclability for pharmaceutical intermediate manufacturing.
Patent CN106220509B reveals ionic liquid catalysis for xanthene diones. Solvent-free, room temp process offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN112812066B reveals a green synthesis method for dihydropyrimidinones using deep eutectic solvents, offering high purity and cost reduction in pharmaceutical intermediates manufacturing.
Advanced ionic liquid catalyzed synthesis of Pyrroloquinoline quinone offers high yield and green processing. Reliable supply chain for nutritional ingredients manufacturing.
Patent CN103450074A discloses a high-selectivity synthesis of R-L-prolinol derivatives. This novel route offers significant cost reduction in chiral catalyst manufacturing.
Novel blue-light mediated method for ((alkylamino)methyl)diphenylphosphine oxides. Mild conditions, high purity, scalable process for pharma intermediates.
Patent CN111574458A reveals a novel chiral catalytic synthesis for high-purity ergothioneine. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN118027091A reveals efficient treprostinil route. Offers supply chain reliability and cost reduction in API manufacturing for global partners.
Patent CN112778351B details a ligand-free, green synthesis of beta-dimethylphenyl silicon substituted aromatic nitro compounds using recyclable cellulose-supported copper nanoparticles.
Patent CN103788069B reveals advanced asymmetric oxidation for esomeprazole magnesium trihydrate. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Advanced preparation method for HER2 inhibitor Tucatinib using Pd(acac)2 catalysis. Offers high purity, simplified purification, and cost-effective manufacturing for pharma supply chains.